Investor Presentation • Nov 8, 2023
Investor Presentation
Open in ViewerOpens in native device viewer

Q3/2023
Sivan Yedidsion – CFO Sivan Yedidsion –CEO David Peretz –CFO
Q1/2023
© AVGOL Nonwovens 2020



Analyst Conference I Who We Are
AVGOL is a world leader in the development, manufacturing and marketing of nonwoven fabrics for diapers, adult incontinence products, disposable feminine hygiene products, disposable medical products, wipes, fabrics used to produce masks, gowns and additional medical products.
The Company also manufactures nonwoven fabrics used as raw or component materials in various non-hygiene products.
Our products are based on polyolefin resins, specifically those in the Polypropylene (PP) family.



~800 employees in the Global commercial and technical team
6 production sites in Israel, USA, China, Russia and India supplying more than 30 countries.
Committed to serve our customers with on-time, in full supply of materials to specification
=
Global leader in the Nonwovens industry, with broad application and end-use touch points


The Public 34.03%


Covering Baby diapers , Feminine Care, Adult Incontinence, PPE and medical


Mainly Polypropylene Spunmelt / Meltblown Biodegradable NW


We aspire to:

Polypropylene (PP) Thermoplastic "addition polymer" made from the combination of propylene monomers and used in a variety of applications, such as packaging for consumer products, plastic parts for various industries, and textiles
6
TECHNOLOGY
Spunbond One continuous process in which fibers are spun and then directly dispersed into a web by deflectors or with air stream. This technology leads to faster belt speeds and cheaper costs
"SMS" Fabrics comprised of one or more Spunbond beams and one or more Meltblown beams in a combination which improves barrier, absorbency, and structural
Meltblown High-velocity air blows molten thermoplastic resin from an extruder die tip onto a conveyor to create random laid nonwoven fabric, a structure useful for filtration and wipes performance Hygiene Baby Care
Hygiene Adult Incontinence Hygiene Feminine Care Other Medical

In December 2022, the company's Board of Directors decided to establish a new production line in our North Carolina, USA facility, as an alternative to the originally planned expansion in Russia.
The addition of this new Reicofil 5 machine will expand the company's existing production capacity by 20K MT annually, offering better efficiency and more advanced products to serve the growing North American market.
Total planned investment : USD 90 million
Commissioning planned during Q4/2024


| USD Mn | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | |
|---|---|---|---|---|---|---|
| Revenues, net | 80.0 | 78.3 | 80.0 | 102.5 | 109.8 | |
| Gross Profit | 13.6 | 10.9 | 11.9 | 19.1 | 18.4 | |
| 16.9% | 13.9% | 14.8% | 18.6% | 16.8% | ||
| EBIT | 7.1 | 3.4 | 4.0 | 9.7 | 8.6 | |
| 8.8% | 4.4% | 5.0% | 9.5% | 7.8% | ||
| 3.5 | 1.5 | 0.8 | 4.7 | 5.5 | ||
| Net Profit | 4.3% | 2.0% | 1.0% | 4.6% | 5.0% | |
| 13.5 | 10.3 | 10.5 | 17.6 | 16.2 | ||
| EBITDA | 16.8% | 13.1% | 13.1% | 17.1% | 14.7% | |
| EBITDA Underlying | 9.6 | 12.0 | 10.0 | 9.4 | 8.6 | |
| 11.9% | 15.3% | 12.5% | 9.2% | 7.9% | ||
| Net Debt/EBITDA | 2.50 | 2.29 | 2.20 | 1.82 | 1.87 |

9 © Avgol Industries 1953 Ltd. 2022

During the third quarter of 2023 and according to the publication date of this report, there is a moderate upward trend in the raw materials price indices. The Company expects this to have a moderate negative impact on its results during the fourth quarter of 2023.

This information is forward-looking information, which is based on the information known by the Company at the time this report is being published. This information might not materialize or might materialize in a way that differs from that anticipated, inter alia, if a material change in trend occurs, or due to other parameters that affect the Company's manufacturing costs or the Company's selling prices
| Results | Q3'23 | Key highlights |
|---|---|---|
| Revenues | \$80M vs \$110M in Q3'2022 | • Decrease in polypropylene prices, to which our sales prices are linked. • A decrease of 4.4% in sales volumes . |
| Gross Profit | \$13.5M vs \$18.4M in Q3'2022 | The Gross Profit in Q3'23 includes a positive impact of about \$3.9M in lag • effect, compared to a positive impact of \$7.5M in Q3'22. • The gross profit was impacted mainly by lower sales volumes and subsequent efficiency rates resulted from lower asset utilization |
| SG&A expenses | \$6.5M vs \$9.0M in Q3'2022 | Driven by significant decrease in logistic rates around the globe and diligent • control of fixed costs. |

\$27

| Results | Q3'23 | Key highlights |
|---|---|---|
| EBITDA | \$13.5M vs \$16.2M in Q3'2022 | EBITDA includes a positive impact of about \$3.9M in lag, compared to a • positive impact of \$7.5M in Q3'22. |
| Underlying EBITDA | \$9.6M vs \$8.6M in Q3'2022 | Mainly due to global decrease in logistics rates ; improved RM purchase • conditions across the board, partially offset lower efficiency rates |
| Net Financing, Expense | \$2.3M vs \$1.2M in Q3'2022 | The increase is a result of a ~\$1.7M decrease in FOREX income • The global increase in interest rates had a moderate impact on the company's • financing expenses due to fixed interest rates on its debt |


| Results | Q3'23 | Key highlights |
|---|---|---|
| Net Profit | \$3.5M vs \$5.5M in Q3'2022 | Mainly influenced by the decrease in the operating profit and • an increase in net financing expense , partially offset by lower income tax expenses. |
| Operating Cash Flow |
\$5.1M vs \$7.2M in Q3'2022 | Mainly influenced by decrease in profits. • |
| Net Working Capital |
\$49M vs \$64M in Q3'2022 | Mainly as a result of decrease in the balances of trade • receivable and Inventory value partially offset by trade payables. |
| Leverage Ratio | 2.5 vs 1.8 in Q4'2022 | Net debt / EBITDA • |


| As on Sep 30 | As on Dec 31 | |
|---|---|---|
| 2023 | 2022 | |
| K'USD | K'USD | |
| CURRENT ASSETS | ||
| Cash and cash equivalents | 45,340 | 61,511 |
| Trade receivables | 33,709 | 47,719 |
| Other receivables and debit balances | 4,087 | 3,913 |
| Current tax assets | 797 | 64 |
| Derivatives | 159 | 1,267 |
| Inventories | 35,679 | 29,918 |
| Total Current Assets | 119,771 | 144,392 |
| NON-CURRENT ASSETS | ||
| Property, plant and equipment, net | 296,578 | 306,275 |
| Right of use asset | 4,836 | 3,802 |
| Derivatives | 149 | 1,212 |
| Deferred tax assets | 2,000 | 489 |
| Long –term Tax balances | 3,695 | 4,346 |
| Intangible assets | 2,162 | 1,910 |
| Long-term debit balances | 3,941 | 3,255 |
| Total Non-current Assets | 313,361 | 321,289 |
| TOTAL ASSETS | 433,132 | 465,681 |
14
| As on Sep 30 | As on Dec 31 | |
|---|---|---|
| 2023 | 2022 | |
| K'USD | K'USD | |
| CURRENT LIABILITIES | ||
| Short-term credit and current maturities of | 11,696 | 13,017 |
| long-term loans from banking corporations | ||
| Nonbank short-term credit | 26,653 | 27,671 |
| Liabilities in respect of derivatives | 544 | 22 |
| Current maturities of long-term bonds | 32,541 | 34,382 |
| Trade payables | 23,790 | 23,450 |
| Current tax liabilities | 22 | 1,288 |
| Other payables and credit balances | 20,234 | 21,856 |
| Total Current Liabilities | 115,480 | 121,686 |
| NON-CURRENT LIABILITIES | ||
| long term payables | 2,086 | 2,679 |
| Long-term loans from banking corporations | 58,380 | 66,217 |
| Bonds | 43,422 | 45,244 |
| Employee benefit liabilities | 155 | 161 |
| Deferred tax liabilities | 17,925 | 19,844 |
| Total Non-current Liabilities | 121,968 | 134,145 |
| EQUITY | ||
| Equity attributable to shareholders of the parent company |
195,369 | 209,484 |
| Noncontrolling interests | 315 | 366 |
| Total Equity | 195,684 | 209,850 |
| Total LIABILITIES AND EQUITY | 433,132 | 465,681 |

© Avgol Industries 1953 Ltd. 2022
Avgol is proud to support our clients with outstanding technical service and support
To find out more about how Avgol can support your baby care diaper range developments, please visit avgol.com or contact us at: [email protected]
We Aspire to Create Nonwoven Innovations to Enhance the Quality of Life

Avgol Industries 1953 Ltd.
9 Shimshon St. Lexus House, 7th floor, Petah Tikva, 4952707 Israel
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.